Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (51-60 of 999) with videos related to

Pageof 100
Sort By:
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 1, 1994
Chronic benign retinal pigment epithelial detachment: a subtype of central serous choroidopathyK Lachapelle, M Ballantyne, A Cruess
Preventive Cardiology|February 6, 2002
The evolving role of high-density lipoprotein in reducing cardiovascular riskC M Ballantyne, G R Rangaraj
The American Journal of Cardiology|December 7, 2002
Combination therapy for combined dyslipidemiaAntonios M Xydakis, Christie M Ballantyne
Clinical Chemistry|December 1, 2020
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and InflammationRon C Hoogeveen, Christie M Ballantyne
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
Advances in lipid testing and management in patients with diabetes mellitusMadhuri M Vasudevan, Christie M Ballantyne
The American Journal of Cardiology|March 1, 2000
Quality assessment and lipid management: considerations for computer databases for tracking patientsB C Short, C M Ballantyne
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 1, 1997
Cardiac output estimation by visual inspection vs thermodilution during cardiac surgeryT Aye, B Milne, M Ballantyne
Current Opinion in Cardiology|November 5, 2003
Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trialsAntonios M Xydakis, Christie M Ballantyne
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of metabolic syndrome: statinsAntonios M Xydakis, Christie M Ballantyne
Diabetes, Obesity & Metabolism|November 1, 2007
How to identify patients with vulnerable plaquesSalim S Virani, Christie M Ballantyne
Pageof 100

Showing results (51-60 of 999) with videos related to

Sort By:
Pageof 100
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 1, 1994
Chronic benign retinal pigment epithelial detachment: a subtype of central serous choroidopathyK Lachapelle, M Ballantyne, A Cruess
Preventive Cardiology|February 6, 2002
The evolving role of high-density lipoprotein in reducing cardiovascular riskC M Ballantyne, G R Rangaraj
The American Journal of Cardiology|December 7, 2002
Combination therapy for combined dyslipidemiaAntonios M Xydakis, Christie M Ballantyne
Clinical Chemistry|December 1, 2020
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and InflammationRon C Hoogeveen, Christie M Ballantyne
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
Advances in lipid testing and management in patients with diabetes mellitusMadhuri M Vasudevan, Christie M Ballantyne
The American Journal of Cardiology|March 1, 2000
Quality assessment and lipid management: considerations for computer databases for tracking patientsB C Short, C M Ballantyne
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 1, 1997
Cardiac output estimation by visual inspection vs thermodilution during cardiac surgeryT Aye, B Milne, M Ballantyne
Current Opinion in Cardiology|November 5, 2003
Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trialsAntonios M Xydakis, Christie M Ballantyne
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of metabolic syndrome: statinsAntonios M Xydakis, Christie M Ballantyne
Diabetes, Obesity & Metabolism|November 1, 2007
How to identify patients with vulnerable plaquesSalim S Virani, Christie M Ballantyne
Pageof 100